1. Home
  2. XBIO vs JCSE Comparison

XBIO vs JCSE Comparison

Compare XBIO & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$3.11

Market Cap

7.2M

Sector

Health Care

ML Signal

HOLD

Logo JE Cleantech Holdings Limited

JCSE

JE Cleantech Holdings Limited

HOLD

Current Price

$1.38

Market Cap

6.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIO
JCSE
Founded
N/A
1999
Country
United States
Singapore
Employees
2
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
6.5M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
XBIO
JCSE
Price
$3.11
$1.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.6K
25.2K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
8.18%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.81
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$0.77
52 Week High
$13.93
$2.50

Technical Indicators

Market Signals
Indicator
XBIO
JCSE
Relative Strength Index (RSI) 55.58 57.04
Support Level $2.94 $1.02
Resistance Level $3.42 $1.46
Average True Range (ATR) 0.15 0.11
MACD 0.01 0.02
Stochastic Oscillator 88.89 57.14

Price Performance

Historical Comparison
XBIO
JCSE

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company has two operating segments namely sale of cleaning systems and other equipment and provision of centralized dishware washing and general cleaning services. Geographically, the company derives a majority of its revenue from Singapore.

Share on Social Networks: